CDK4 and breast carcinoma: The presence of the BCSCs is also regarded as the main cause of resistance to hormonal therapy in luminal breast cancer (113, 114), which can be regulated by the CyclinD-CDK4/6 (cyclin-dependent kinase 4/6) complex (115, 116) and mTOR signaling (117) (Figure 2, Table 2).